Navigation Links
Neurocrine Biosciences Announces Conference Call and Webcast to Report Second Quarter 2015 Results
Date:7/22/2015

SAN DIEGO, July 22, 2015 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that the Company will report its second quarter 2015 financial results after the Nasdaq market closes on Wednesday, July 29, 2015.  Neurocrine will then host a live conference call and webcast to discuss its financial results and provide a Company update Wednesday afternoon, July 29, 2015 at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time).

Participants can access the live conference call by dialing ­­­­­­­866-952-1906 (US) or 785-424-1825 (International) using the conference ID: NBIX. The call can also be accessed via the webcast through the Company's website at http://www.neurocrine.com.

If you are unable to attend the webcast and would like further information on this announcement please contact the Investor Relations Department at Neurocrine Biosciences at (858) 617-7600.  A replay of the conference call will be available approximately one hour after the conclusion of the call by dialing 800-695-2185 (US) or 402-530-9028 (International) using the conference ID: NBIX. The call will be archived for one month.

Neurocrine Biosciences, Inc. discovers and develops innovative and life-changing pharmaceuticals, in diseases with high unmet medical needs, through its novel R&D platform, focused on neurological and endocrine based diseases and disorders.  The Company's two lead late-stage clinical programs are elagolix, a gonadotropin-releasing hormone antagonist for women's health that is partnered with AbbVie Inc., and NBI-98854, a vesicular monoamine transporter 2 inhibitor for the treatment of movement disorders.  Neurocrine intends to maintain certain commercial rights to its VMAT2 inhibitor for evolution into a fully-integrated pharmaceutical company.  Neurocrine Biosciences, Inc. news releases are available through the Company's website via the internet at http://www.neurocrine.com.

 

 


'/>"/>
SOURCE Neurocrine Biosciences, Inc.
Copyright©2015 PR Newswire.
All rights reserved

Related medicine technology :

1. Neurocrine Biosciences Provides Update on NBI-77860 Program for Congenital Adrenal Hyperplasia
2. Neurocrine Biosciences to Host Analyst and Investor Day in New York City on May 21, 2015
3. Neurocrine Biosciences to Present at the Bank of America Merrill Lynch 2015 Health Care Conference
4. Neurocrine Biosciences, Inc. Announces Appointment of Dr. Bill Aurora as Vice President, Medical Affairs
5. Neurocrine Biosciences to Present at the Deutsche Bank 40th Annual Health Care Conference
6. Neurocrine Biosciences Reports First Quarter 2015 Results
7. Pre-market Equity Watch on Biotech -- ARIAD Pharma, Array BioPharma, Neurocrine Biosciences, Coronado Biosciences, and Ironwood Pharma
8. Neurocrine Biosciences and Mitsubishi Tanabe Pharma Announce Agreement to Develop and Commercialize VMAT2 Inhibitor NBI-98854 for Movement Disorders in Japan and Other Select Asian Markets
9. Neurocrine Biosciences, Inc. Announces Exercise in Full of Underwriters Option to Purchase Additional Shares
10. Neurocrine Biosciences, Inc. Prices Public Offering of Common Stock
11. Neurocrine Biosciences, Inc. Announces Proposed Public Offering of $225 Million of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2019)... MINNEAPOLIS (PRWEB) , ... November 22, 2019 , ... ... Portner was recognized as a Circle of Excellence honoree at the Finance and ... Finance are honored for their significant career achievements and for their impressive impact ...
(Date:11/22/2019)... (PRWEB) , ... November 22, 2019 , ... ... dental implantology at Misch International Implant Institute. Completing this three-year program enhances Dr. ... SC patients who are seeking permanent tooth replacement solutions. The Misch International Implant ...
(Date:11/22/2019)... ... November 22, 2019 , ... Board-certified oral surgeons, Drs. Joel ... patients improve their speech, eating and swallowing through jaw surgery in their Manchester ... can help improve the function and aesthetic look of a flawed jaw. ...
Breaking Medicine Technology:
(Date:11/23/2019)... ... ... AIS Network has been selected as an award winner in the ... — recognizes the world’s best digital health resources. , The Northern Virginia Mental ... Digital Health/Responsive Website Design. , “We were delighted to participate in the ...
(Date:11/23/2019)... MONTREAL (PRWEB) , ... November 23, 2019 , ... The ... process complex information, store memories, as well as strategize and plan. In a world ... ability to deliberate carefully before taking action should be praised, should it not? But ...
(Date:11/22/2019)... ... 22, 2019 , ... This year Grupo Sunset World continues its social commitment ... donating 5 rooms for one week stays at Hacienda Tres Ríos Resort, Spa & ... come to the Riviera Maya to complete the healing process and feel alive again ...
(Date:11/22/2019)... (PRWEB) , ... November 21, 2019 , ... Desert ... LLC., a national network of veterinary practices. The deal closed on September 20th, ... said Dr. Wyatt Winchell, DVM at Desert Pines Equine Medical & Surgical Center. “We ...
(Date:11/22/2019)... , ... November 21, 2019 , ... ... it has received DEA approval to ship THC and CBD from Canada. MMJ ... from the marijuana plant containing THC and CBD. MMJ will be utilizing its ...
Breaking Medicine News(10 mins):